CD274 and cancer: Later, in a study involving 83 GBC patients, PD-L1 expression on both cancer cells and tumor-infiltrating lymphocytes (TILs) and PD-1 expression on TILs were investigated, and expression levels were found in 15.7%, 13.3% and 51.8%, respectively [59].